• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wall Street's Most Accurate Analysts' Views On 3 Risk Off Stocks Delivering High-Dividend Yields

    5/22/24 9:10:03 AM ET
    $ENR
    $MO
    $PM
    Industrial Machinery/Components
    Miscellaneous
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ENR alert in real time by email

    During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

    Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy .

    Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.

    Altria Group, Inc. (NYSE:MO)

    • Dividend Yield: 8.46%
    • Stifel analyst Matthew Smith reiterated a Buy rating with a price target of $50 on March 25. This analyst has an accuracy rate of 65%.
    • Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating with a price target of $45 on July 18, 2023. This analyst has an accuracy rate of 68%.
    • Recent News: On April 25, Altria Group reported a first-quarter FY24 sales decline of 2.5% year-on-year to $5.58 billion, beating the analyst consensus estimate of $4.71 billion.

    Philip Morris International Inc. (NYSE:PM)

    • Dividend Yield: 5.19%
    • Stifel analyst Matthew Smith maintained a Buy rating and boosted the price target from $108 to $115 on April 24. This analyst has an accuracy rate of 65%.
    • Argus Research analyst David Colemandowngraded the stock from Buy to Hold on March 5. This analyst has an accuracy rate of 62%.
    • Recent News: On April 23, Philip Morris International reported first-quarter FY24 sales growth of 9.7% year-on-year to $8.793 billion, beating the analyst consensus estimate of $8.468 billion..

    Energizer Holdings, Inc. (NYSE:ENR)

    • Dividend Yield: 3.95%
    • Barclays analyst Lauren Lieberman maintained an Overweight rating and cut the price target from $32 to $31 on May 9. This analyst has an accuracy rate of 62%.
    • Morgan Stanley analyst Dara Mohsenianupgraded the stock from Underweight to Equal-Weight with a price target of $33 on May 8. This analyst has an accuracy rate of 74%.
    • Recent News: On May 7, Energizer Hldgs posted better-than-expected quarterly earnings.

    Read More: Target, Nvidia And 3 Stocks To Watch Heading Into Wednesday

    Get the next $ENR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ENR
    $MO
    $PM

    CompanyDatePrice TargetRatingAnalyst
    Philip Morris International Inc
    $PM
    1/20/2026$180.00Buy → Hold
    Jefferies
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Philip Morris International Inc
    $PM
    7/9/2025$220.00Buy
    Jefferies
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Philip Morris International Inc
    $PM
    5/22/2025$195.00Buy
    Needham
    Philip Morris International Inc
    $PM
    4/25/2025$170.00Sell → Neutral
    UBS
    Altria Group Inc.
    $MO
    4/1/2025Buy → Hold
    Deutsche Bank
    More analyst ratings

    $ENR
    $MO
    $PM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast

    Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, and Group Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference at approximately 10:00 a.m. ET. The live webcast and presentation slides will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The presentation will cover: How a transformed PMI is leading the industry in an evolving operating environment; The success and future opportu

    2/18/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance

    Altria Group, Inc. (Altria) (NYSE:MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida, today. Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer, will highlight the portfolio we are building to capture the growing smoke-free opportunity, discuss how we are evolving our business and capabilities to lead the U.S. nicotine space and provide more detail on our long-term growth aspirations. Remarks and Presentation The presentation will be webcast live on www.altria.com in a listen-only mode, beginning at approximately 1:00 p.m. Eastern Time. A copy of the business pr

    2/18/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $ENR
    $MO
    $PM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mulligan Donal L bought $261,000 worth of shares (15,000 units at $17.40) (SEC Form 4)

    4 - ENERGIZER HOLDINGS, INC. (0001632790) (Issuer)

    12/3/25 5:48:16 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Lavigne Mark Stephen bought $171,100 worth of shares (10,000 units at $17.11), increasing direct ownership by 2% to 464,889 units (SEC Form 4)

    4 - ENERGIZER HOLDINGS, INC. (0001632790) (Issuer)

    12/2/25 4:44:24 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    Chief Administrative Officer Angelette Benjamin J bought $17,140 worth of shares (1,000 units at $17.14), increasing direct ownership by 3% to 40,896 units (SEC Form 4)

    4 - ENERGIZER HOLDINGS, INC. (0001632790) (Issuer)

    12/2/25 4:44:16 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    $ENR
    $MO
    $PM
    SEC Filings

    View All

    SEC Form 10-K filed by Altria Group Inc.

    10-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    2/25/26 1:51:59 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 25-NSE filed by Philip Morris International Inc

    25-NSE - Philip Morris International Inc. (0001413329) (Subject)

    2/25/26 11:26:48 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Philip Morris International Inc. (0001413329) (Filer)

    2/18/26 10:04:09 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $ENR
    $MO
    $PM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and COO Begley Jody L was granted 22,448 shares, increasing direct ownership by 8% to 313,227 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/27/26 1:07:38 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Vice President and Controller Patterson Katie F was granted 1,432 shares, increasing direct ownership by 8% to 18,357 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/27/26 1:07:53 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    EVP & General Counsel Mccarter Robert A. Iii was granted 22,448 shares, increasing direct ownership by 22% to 122,362 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/27/26 1:07:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $ENR
    $MO
    $PM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Philip Morris International downgraded by Jefferies with a new price target

    Jefferies downgraded Philip Morris International from Buy to Hold and set a new price target of $180.00

    1/20/26 9:10:49 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Jefferies resumed coverage on Philip Morris International with a new price target

    Jefferies resumed coverage of Philip Morris International with a rating of Buy and set a new price target of $220.00

    7/9/25 8:31:10 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $ENR
    $MO
    $PM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Energizer Holdings Inc.

    SC 13G/A - ENERGIZER HOLDINGS, INC. (0001632790) (Subject)

    8/9/24 1:40:34 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Energizer Holdings Inc. (Amendment)

    SC 13G/A - ENERGIZER HOLDINGS, INC. (0001632790) (Subject)

    2/14/24 12:37:04 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Energizer Holdings Inc. (Amendment)

    SC 13G/A - ENERGIZER HOLDINGS, INC. (0001632790) (Subject)

    2/13/24 5:04:31 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    $ENR
    $MO
    $PM
    Leadership Updates

    Live Leadership Updates

    View All

    Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

    The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta

    1/20/26 5:03:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of Director George Muñoz from Board of Directors

    Altria Group, Inc. (Altria) (NYSE:MO) -- George Muñoz, a director of Altria since 2004, notified Altria of his decision to retire from service on our Board of Directors (Board) following the completion of his current term. Consequently, Mr. Muñoz will not stand for re-election to our Board at our 2026 Annual Meeting of Shareholders, which Altria anticipates holding on May 14, 2026. "George has made extensive and significant contributions to Altria over more than 20 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank George for his long-standing and valuable service and wish him the very best upon his retirement." Mr. Muñoz is Chair of the Compensation and Ta

    10/9/25 8:35:00 AM ET
    $LAUR
    $MO
    Other Consumer Services
    Real Estate
    Medicinal Chemicals and Botanical Products
    Health Care

    $ENR
    $MO
    $PM
    Financials

    Live finance-specific insights

    View All

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast

    Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, and Group Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference at approximately 10:00 a.m. ET. The live webcast and presentation slides will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The presentation will cover: How a transformed PMI is leading the industry in an evolving operating environment; The success and future opportu

    2/18/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Reports 2025 Fourth-Quarter & Full-Year Results

    Delivers Full Year 2025 Reported Diluted EPS of $7.26 compared to $4.52 in 2024 and Adjusted Diluted EPS of $7.54, Representing Growth of 14.8%, and 14.2% on a Currency-Neutral Basis; Provides 2026 - 2028 Growth Targets Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2025 fourth quarter results.1 "We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good operating margin expansion," said Jacek Olczak, Group CEO PMI. "With excellent results in 2024 and 2025, we have delivered our three-year CA

    2/6/26 6:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care